Banda H, Robinson R, Thomson R, Squire S B, Mortimer K
Research for Equity and Community Health Trust, Lilongwe, Malawi.
Department of Clinical Sciences and Centre for Applied Health Research and Delivery, Liverpool School of Tropical Medicine, Liverpool, UK.
Int J Tuberc Lung Dis. 2016 Apr;20(4):552-9. doi: 10.5588/ijtld.15.0613.
There is a high burden of respiratory disease in sub-Saharan Africa. To address this problem, the World Health Organization launched the 'Practical approach to Lung Health' (PAL), i.e., locally applicable integrated syndromic algorithms, to improve primary care management of these diseases.
To examine the evidence for the impact of PAL on the diagnosis and management of tuberculosis (TB) and other common respiratory problems in sub-Saharan Africa.
A systematic review of MEDLINE (1998-2015), EMBASE (1998-2015) and CINAHL (1998-2015) was conducted to find trials evaluating PAL implementation in sub-Saharan Africa.
Five studies were found, evaluating three PAL variations: PAL in South Africa (PALSA), PALSA with integrated human immunodeficiency virus treatment (PALSA PLUS) and PAL in Malawi using lay health workers (PALM/LHW). PALSA increased TB diagnosis (OR 1.72, 95%CI 1.04-2.85), as did PALSA PLUS (OR 1.25, 95%CI 1.01-1.55). Cure or completion rates in retreatment cases in PALSA and PALSA PLUS were significantly improved (OR 1.78, 95%CI 1.13-2.76). PALM/LHW, which examined TB treatment success, found no significant improvement (P = 0.578).
The limited research performed shows that PAL can be effective in TB diagnosis and partial treatment success; however, more evidence is needed to assess its effects on other respiratory diseases, especially in wider sub-Saharan Africa.
撒哈拉以南非洲地区呼吸系统疾病负担沉重。为解决这一问题,世界卫生组织推出了“肺部健康实用方法”(PAL),即适用于当地的综合症状算法,以改善这些疾病的初级保健管理。
研究PAL对撒哈拉以南非洲地区结核病(TB)及其他常见呼吸问题的诊断和管理的影响证据。
对MEDLINE(1998 - 2015年)、EMBASE(1998 - 2015年)和CINAHL(1998 - 2015年)进行系统综述,以查找评估PAL在撒哈拉以南非洲地区实施情况的试验。
共找到五项研究,评估了三种PAL变体:南非的PAL(PALSA)、结合人类免疫缺陷病毒治疗的PALSA(PALSA PLUS)以及马拉维使用非专业卫生工作者的PAL(PALM/LHW)。PALSA增加了结核病诊断率(比值比1.72,95%置信区间1.04 - 2.85),PALSA PLUS也是如此(比值比1.25,95%置信区间1.01 - 1.55)。PALSA和PALSA PLUS中复治病例的治愈或完成治疗率显著提高(比值比1.78,95%置信区间1.13 - 2.76)。研究结核病治疗成功率的PALM/LHW未发现显著改善(P = 0.578)。
所进行的有限研究表明,PAL在结核病诊断和部分治疗成功方面可能有效;然而,需要更多证据来评估其对其他呼吸系统疾病的影响,尤其是在更广泛的撒哈拉以南非洲地区。